Description
Survodutide 5 mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
Not licensed by the MHRA. Not a medicinal product.
Research-grade synthetic peptide supplied as a 5 mg sealed vial for lawful laboratory research in the UK. Not a food, supplement or medical device on this page. Not for diagnostic or therapeutic use. Must not be administered to people or animals.
This vial is not semaglutide, tirzepatide or retatrutide and is not an authorised medicine.
Identification
| Product name | Survodutide |
| Also listed as | BI 456906 |
| Research class | Dual glucagon / GLP-1 receptor analogue (research ligand) |
| Supplier | Opti-Gen Peptides |
| Contents | 5 mg per vial |
| CAS (commonly cited) | 2805997-46-8 |
| Approx. mass | ~3991 Da |
| Intended use | Laboratory / in-vitro research only |
Confirm identity on the lot COA.
Quality / storage
Only the lot COA applies. Store as a laboratory peptide under institutional SOP. No pen, dose or injection instructions on this page.
Published research context (not product claims)
Survodutide is a glucagon/GLP-1 receptor dual analogue from Boehringer Ingelheim / Zealand chemistry. Receptor papers describe dual-agonist pharmacology in experimental systems.
Clinical-development publications cover phase 2 programmes in metabolic and liver-research settings. Those papers concern investigational drug products, not this research vial.
Any future marketing authorisation would apply only to approved drug products. It must not be rewritten as a weight-loss or NASH claim here.
There is no UK marketing authorisation for this listing.
UK notice
18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.
Reviews
There are no reviews yet.